InvestorsHub Logo
Followers 39
Posts 1714
Boards Moderated 0
Alias Born 10/05/2005

Re: IgnoranceIsBliss post# 152485

Thursday, 10/25/2018 4:27:05 PM

Thursday, October 25, 2018 4:27:05 PM

Post# of 426531
Yes I'm not sure where they would go from here assuming that they stay within their core competencies. Cardiovascular is a tough market and all of the big indications have lots of generics, leaving only niche markets.

I could see, possibly, a combo pill with a statin a la Caduet.

PS: Hi!
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AMRN News